The Convergence of Down Syndrome and Alzheimer’s Disease — Scientific and Ethical Imperatives

The article addresses the relationship between Down syndrome and Alzheimer's disease. Individuals with Down syndrome have a significantly increased risk of developing Alzheimer's disease compared to the general population. This phenomenon is associated with genetic factors, specifically the presence of a third copy of chromosome 21, which leads to excessive accumulation of amyloid proteins in the brain. The article emphasizes the need for better understanding of the mechanisms underlying this convergence to develop new therapeutic approaches. It also highlights ethical challenges associated with diagnosis and treatment of these conditions in individuals with Down syndrome. Research in this area has the potential to contribute to understanding Alzheimer's disease in the broader population.